Sep 15, 2026 08:00AM
Sep 14, 2026 08:30AM
Sep 11, 2026 08:31AM
Sep 11, 2026 08:30AM
Sep 11, 2026 08:30AM
Sep 10, 2026 08:30AM
Sep 9, 2026 08:32AM Quantum BioPharma gets FDA clearance for MS drug trial
Sep 9, 2026 08:30AM
Sep 8, 2026 08:30AM
Aug 14, 2026 07:00AM
Aug 14, 2026 07:00AM
Aug 10, 2026 07:00AM
Aug 10, 2026 07:00AM
Jun 24, 2026 08:30AM The Quest to Repair What Multiple Sclerosis Takes Away
Jun 22, 2026 08:30AM
May 18, 2026 05:08AM
May 18, 2026 03:00AM
May 7, 2026 07:02AM
May 7, 2026 07:00AM
Apr 1, 2026 08:04AM
Apr 1, 2026 08:02AM Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
Mar 26, 2026 08:00AM
Mar 26, 2026 08:00AM
Dec 23, 2025 08:02AM
Dec 23, 2025 08:00AM
Nov 7, 2025 07:00AM
Oct 23, 2025 08:15AM
Oct 2, 2025 07:57AM Quantum BioPharma receives toxicity study reports for MS drug
Oct 2, 2025 07:57AM
Sep 29, 2025 07:44AM
Sep 29, 2025 07:40AM
Aug 21, 2025 07:00AM
Aug 11, 2025 07:40AM
Aug 11, 2025 07:40AM
Aug 7, 2025 07:01AM Quantum BioPharma reports Q2 gains with debt conversion to equity
Aug 7, 2025 07:00AM
Aug 5, 2025 07:34AM
Aug 5, 2025 07:34AM
Jun 18, 2025 09:19AM
May 20, 2025 07:31AM
May 20, 2025 07:30AM
May 12, 2025 08:04AM Quantum BioPharma (QNTM) Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis
May 12, 2025 08:00AM
Mar 28, 2025 09:16AM
Mar 28, 2025 09:15AM
Mar 28, 2025 04:30AM
Mar 26, 2025 07:00AM
Oct 7, 2024 08:43AM
Oct 7, 2024 08:40AM Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South Ame
Oct 7, 2024 08:02AM

331,401 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All